Insights for FDA Regulated and HIPAA Compliant Organizations

Volatile times demand pervasive visibility and flexibility. Cost and currency fluctuations, supply disruptions, transportation capacity constraints and production recalls all put pressure on productivity. Supply chain executives are under ever increasing stress – if there is even one misstep – your whole supply chain and its extended network can be...

Innovation is a critical capability for diagnostic and genomic testing organizations to help them identify and bring new life-changing discoveries to patients. The real-world outcomes would suggest that life sciences organizations are rapidly improving their success at unlocking new answers.  However, based on industry research, it is clear th...

For diagnostic testing and medical device companies, global business plays a critical role in delivering life-saving and life-enhancing therapies for an exponentially increasing number of patients daily. Lately, third-party logistics providers (3PL's) are focusing on ways in which they can deliver optimal service to their customers. This involves p...

The rapid pace of process innovation and technological advancement in the last decade has introduced both significant benefits as well as significant challenges to FDA regulated industries.  Learn More about TAGmedica  Companies these days are faced with demands of bringing products to market faster and faster, not only to meet sales and ...

Finding the Right Partners is the Key Inherent with the goal of commercialization lies the problems of production and distribution methods and costs, which must be worked out before manufacturing begins. FDA regulated companies are looking for a shorter and less costly pathway to commercialism, especially for smaller diagnostic testing companies. T...